-
Aug 27, 2015, 08:14
by
Michael Croft
PRINCETON, NJ - Aug 27, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that its Director of Pharmacometrics Samer Mouksassi, PharmD, PhD, FCP, has been appointed an associate professor in the Faculty of Pharmacy at the University of Montreal
Full story
-
Aug 26, 2015, 13:25
by
Michael Croft
FierceBiotech | Researchers at Memorial Sloan Kettering Cancer Center have published the results of a Phase II trial to extend the indications for cancer therapy Zelboraf, in a "basket trial" protocol that divides patients by key biomarkers rather than broad disease types.
Full story
-
Aug 25, 2015, 14:50
by
Michael Croft
Forbes | In a new twist on its retail health clinic model, Walgreens says it will open up to 25 new retail clinics in Oregon and Washington states that will be owned and operated by a Seattle-based health system.
Full story
-
Aug 24, 2015, 15:20
by
Michael Croft
NPR.org | In a surprising improvement, access to primary care in New Orleans has improved since Katrina, even after much of the city's medical infrastructure collapsed. There are still holes, though, for mental health care and the poor.
Full story
-
Aug 20, 2015, 14:55
by
Michael Croft
Clinical Informatics News | Yesterday, the Rare Genomics (RG) Institute announced the winners of the 2015 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge, a global competition that offers technology tools to rare disease researchers. Tools and technology were provided by Jackson Lab, Taconic Biosciences, Tute Genomics, Cypher Genomics, Maverix Biomics, Biovista, and more.
Full story
-
Aug 20, 2015, 10:50
by
Michael Croft
PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J
Full story
-
Aug 20, 2015, 10:00
by
Michael Croft
TIME | The brain cancer patient featured on the March cover of TIME is cancer-free, thanks to a clinical trial methodology researchers called a "basket trial". In a follow up article, TIME recounts her progress and Rather than group cancers by tissue of origin, the trial grouped 122 cancer patients by driving mutation, then tested drugs thought to target those mutations.
Full story
-
Aug 20, 2015, 09:05
by
Michael Croft
WSJ | After years of effort, scientists and families of young patients with a rare genetic condition are facing the prospect of three companies launching clinical trials to develop therapies. But can the community support more than one trial at the same time?
Full story
-
Aug 18, 2015, 17:28
by
Michael Croft
MIDDLETON, WI, UNITED STATES - Aug 18, 2015 - PFS Clinical, which offers turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its clinical research trials
Full story
-
Aug 18, 2015, 15:15
by
Michael Croft
Nature News & Comment | A study showing a fall in positive trial results after the roll-out of clinicaltrials.gov. Having to state methods and measurements before starting a trial precluded cherry-picking data afterward, the authors theorized.
Full story
-
Aug 13, 2015, 07:00
by
Michael Croft
Clinical Informatics News | We’re told that modern technologies are dramatically transforming healthcare for the better. We need a reality check. This grand vision is not yet clear for many of us testing the science of digital health and seeking to understand how it will improve care. Digital health is at its infancy.
Full story
-
Aug 12, 2015, 10:35
by
Michael Croft
Xconomy | A system that uses electronic health records data to better match eligible patients with clinical trials took the top prize in the first round of the Clinical Trial Innovation Prize.
Full story
-
Aug 12, 2015, 09:30
by
Michael Croft
WIRED | The new partnership will allow Yelp users to see emergency room waiting times at hospitals, among other useful information about healthcare services.
Full story
-
Aug 11, 2015, 14:00
by
Michael Croft
Clinical Informatics News Brief | Minorities are under-represented in clinical trials even as they carry greater disease burden, particularly for cardiovascular diseases. Dr. Priscilla Pemu, director of clinical trials at Morehouse School of Medicine, spoke with NPR about the challenges and opportunities increasing the number of minorities in clinical trials.
Full story
-
Aug 11, 2015, 12:45
by
Michael Croft
Techdirt | The TransPacific Partnership is stalled on data exclusivity--the protection of clinical trial data submitted to regulatory agencies from use by competitors. US pharma companies want the TPP to require a 12 year period of data exclusivity for clinical trial data for biologics.
Full story
-
Aug 10, 2015, 11:55
by
Michael Croft
SearchHealthIT | The CEO of Allscripts revealed the company's corporate strategy to compete with Epic and Cerner. The key to its comeback bid is a new genomics system deal with NantHealth.
Full story
-
Aug 10, 2015, 11:00
by
Michael Croft
Washington Post | As a new FDA medical officer in 1960, Kelsey fought for more safety testing for the morning sickness drug thalidomide - efforts that prevented perhaps thousands of birth defects and led to meaningful new drug regulations.
Full story
-
Aug 7, 2015, 12:55
by
Michael Croft
Clinical Informatics News Brief | A workgroup convened by the American College of Emergency Physicians, in support of a proposed national Health Information Exchange, has published a set of priority items for improving the usefulness of these exchanges in emergency care.
Full story
-
Aug 7, 2015, 10:40
by
Michael Croft
New York Times | IBM has announced the $1 billion purchase of Merge Healthcare, whose software for managing huge volumes of medical imaging data will now be linked to IBM's Watson machine learning programs in healthcare.
Full story
-
Aug 4, 2015, 14:30
by
Michael Croft
Clinical Informatics News Roundup | Over the weekend, the popular philosopher Steven Pinker published an opinion piece in the Boston Globe titled “The moral imperative for bioethics,” which has set off a flurry of blog posts and ripostes about the nature and purpose of bioethical review in medical research.
Full story